Related Experiment Video
Updated: Jul 13, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
Published on: June 30, 2018
Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease
1Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, California 90502, USA. rmehrotra@labiomed.org
Insights
Vascular calcification is common in dialysis patients due to chronic kidney disease. Fetuin-A levels impact calcification and mortality, but its role in different chronic kidney disease stages needs more research.
Area of Science:
- Nephrology
- Vascular Biology
- Biochemistry
Background:
- Vascular calcification (VC) significantly contributes to vascular disease burden in chronic dialysis patients.
- Chronic kidney disease (CKD) disrupts the balance of VC promoters and inhibitors.
- Fetuin-A, a calcification inhibitor, plays a critical role in regulating osteogenesis.
Discussion:
- Low fetuin-A levels correlate with increased VC prevalence, severity, and mortality risk.
- High fetuin-A levels may induce insulin resistance and are linked to VC in diabetic nephropathy.
- The dual role of fetuin-A necessitates further investigation across different CKD stages.
Key Insights:
- Fetuin-A's circulating levels are a key determinant in vascular calcification.
- Both low and high fetuin-A levels present distinct risks in CKD patients.
- Understanding fetuin-A's complex role is crucial for managing vascular complications.
Outlook:
- Further research is needed to elucidate fetuin-A's systemic effects in health and CKD.
- Clarifying fetuin-A's role may lead to novel therapeutic strategies for vascular disease.
- Investigating fetuin-A's impact across the spectrum of CKD is essential.
Abstract:
Vascular calcification (VC) is an important reason for the high burden of vascular disease among chronic dialysis patients. Chronic kidney disease (CKD) is associated with increased promoters and decreased inhibitors of VC. The circulating levels of fetuin-A, a well-described inhibitor of calcification, regulate the cell-dependent process of osteogenesis. It is not surprising that the low circulating fetuin-A levels are associated with a greater prevalence and/or severity of VC and increased risk for all-cause and cardiovascular mortality. However, high circulating fetuin-A levels appear to induce insulin resistance and, in non-dialyzed subjects with diabetic nephropathy, are directly related to VC burden. These findings underscore the need to further clarify the multiple, systemic effects of fetuin-A and its role in health and various stages of CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome I : Introduction
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy